These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 34942385)
21. [Transplantation of genetically modified cells in the treatment of children with SCID: great hopes and recent disappointments]. Smogorzewska EM; Weinberg KI; Kohn DB Med Wieku Rozwoj; 2003; 7(1):27-34. PubMed ID: 13130167 [TBL] [Abstract][Full Text] [Related]
22. Haploidentical bone marrow transplantation for severe combined immunodeficiency disease using soybean agglutinin-negative, T-depleted marrow cells. Cowan MJ; Wara DW; Weintrub PS; Pabst H; Ammann AJ J Clin Immunol; 1985 Nov; 5(6):370-6. PubMed ID: 3910675 [TBL] [Abstract][Full Text] [Related]
23. Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients. Haddad E; Landais P; Friedrich W; Gerritsen B; Cavazzana-Calvo M; Morgan G; Bertrand Y; Fasth A; Porta F; Cant A; Espanol T; Müller S; Veys P; Vossen J; Fischer A Blood; 1998 May; 91(10):3646-53. PubMed ID: 9573000 [TBL] [Abstract][Full Text] [Related]
24. Kinetics of T-cell development of umbilical cord blood transplantation in severe T-cell immunodeficiency disorders. Knutsen AP; Wall DA J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):823-32. PubMed ID: 10329816 [TBL] [Abstract][Full Text] [Related]
25. Influence of severe combined immunodeficiency phenotype on the outcome of HLA non-identical, T-cell-depleted bone marrow transplantation: a retrospective European survey from the European group for bone marrow transplantation and the european society for immunodeficiency. Bertrand Y; Landais P; Friedrich W; Gerritsen B; Morgan G; Fasth A; Cavazzana-Calvo M; Porta F; Cant A; Espanol T; Müller S; Veys P; Vossen J; Haddad E; Fischer A J Pediatr; 1999 Jun; 134(6):740-8. PubMed ID: 10356144 [TBL] [Abstract][Full Text] [Related]
26. Neonatal bone marrow transplantation of ADA-deficient SCID mice results in immunologic reconstitution despite low levels of engraftment and an absence of selective donor T lymphoid expansion. Carbonaro DA; Jin X; Cotoi D; Mi T; Yu XJ; Skelton DC; Dorey F; Kellems RE; Blackburn MR; Kohn DB Blood; 2008 Jun; 111(12):5745-54. PubMed ID: 18356486 [TBL] [Abstract][Full Text] [Related]
27. Host natural killer immunity is a key indicator of permissiveness for donor cell engraftment in patients with severe combined immunodeficiency. Hassan A; Lee P; Maggina P; Xu JH; Moreira D; Slatter M; Nademi Z; Worth A; Adams S; Jones A; Cale C; Allwood Z; Rao K; Chiesa R; Amrolia P; Gaspar H; Davies EG; Veys P; Gennery A; Qasim W J Allergy Clin Immunol; 2014 Jun; 133(6):1660-6. PubMed ID: 24794685 [TBL] [Abstract][Full Text] [Related]
29. Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival. Myers LA; Patel DD; Puck JM; Buckley RH Blood; 2002 Feb; 99(3):872-8. PubMed ID: 11806989 [TBL] [Abstract][Full Text] [Related]
30. Long-term outcome of non-ablative booster BMT in patients with SCID. Teigland CL; Parrott RE; Buckley RH Bone Marrow Transplant; 2013 Aug; 48(8):1050-5. PubMed ID: 23396406 [TBL] [Abstract][Full Text] [Related]
31. The Cape Town experience with haematopoietic stem cell transplantation: the paediatric programme. Roux P; Novitzky N S Afr Med J; 2000 Aug; 90(8):804-11. PubMed ID: 11022631 [TBL] [Abstract][Full Text] [Related]
32. Clinical characteristics and genetic profiles of 44 patients with severe combined immunodeficiency (SCID): report from Shanghai, China (2004-2011). Yao CM; Han XH; Zhang YD; Zhang H; Jin YY; Cao RM; Wang X; Liu QH; Zhao W; Chen TX J Clin Immunol; 2013 Apr; 33(3):526-39. PubMed ID: 23250629 [TBL] [Abstract][Full Text] [Related]
33. Neonatal bone marrow transplantation for severe combined immunodeficiency. Kane L; Gennery AR; Crooks BN; Flood TJ; Abinun M; Cant AJ Arch Dis Child Fetal Neonatal Ed; 2001 Sep; 85(2):F110-3. PubMed ID: 11517204 [TBL] [Abstract][Full Text] [Related]
35. Recommendations for Screening and Management of Late Effects in Patients with Severe Combined Immunodeficiency after Allogenic Hematopoietic Cell Transplantation: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT. Heimall J; Buckley RH; Puck J; Fleisher TA; Gennery AR; Haddad E; Neven B; Slatter M; Roderick S; Baker KS; Dietz AC; Duncan C; Griffith LM; Notarangelo L; Pulsipher MA; Cowan MJ Biol Blood Marrow Transplant; 2017 Aug; 23(8):1229-1240. PubMed ID: 28479164 [TBL] [Abstract][Full Text] [Related]
36. The kinetics of early T and B cell immune recovery after bone marrow transplantation in RAG-2-deficient SCID patients. Lev A; Simon AJ; Bareket M; Bielorai B; Hutt D; Amariglio N; Rechavi G; Somech R PLoS One; 2012; 7(1):e30494. PubMed ID: 22295088 [TBL] [Abstract][Full Text] [Related]
37. Hematopoietic Stem Cell Transplant for Primary Immunodeficiency Diseases: A Single-Center Experience. Patiroglu T; Akar HH; Unal E; Ozdemir MA; Karakukcu M Exp Clin Transplant; 2017 Jun; 15(3):337-343. PubMed ID: 27001505 [TBL] [Abstract][Full Text] [Related]